| BSE: 500672 | Sector: Health care |
| NSE: NOVARTIND | ISIN Code: INE234A01025 |
| BSE 00:00 | 16 Nov | 704.00 |
1.20 (0.17%) |
OPEN
704.95 |
HIGH
715.00 |
LOW
690.60 |
| NSE 05:30 | 01 Jan | Novartis India Ltd Not listed in NSE |
| OPEN | 704.95 |
| PREVIOUS CLOSE | 702.80 |
| VOLUME | 6504 |
| 52-Week high | 980.00 |
| 52-Week low | 590.00 |
| P/E | 32.61 |
| Mkt Cap.(Rs cr) | 1,739 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals, Generics, Over the Trade Counter and...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
1,739 | |
| EPS - TTM | () |
[*S] | 21.59 |
| P/E Ratio | (X) | [*S] | 32.61 |
| Face Value | () |
5 | |
| Latest Dividend | (%) | 200.00 | |
| Latest Dividend Date | 18 Jul 2018 | ||
| Dividend Yield | (%) | 1.42 | |
| Book Value / Share | () |
[*S] | 294.04 |
| P/B Ratio | () |
[*S] | 2.39 |
Financial Results For The Second Quarter And Half Year Ended September 30 2018
Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) R
Compliance Certificate For Half Year Ended September 302018.
Statement Of Investor Complaints For The Quarter Ended September 2018
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 106.58 | 167.65 | -36.43 |
| Other Income | 31.08 | 25.1 | 23.82 |
| Total Income | 137.66 | 192.75 | -28.58 |
| Total Expenses | 124.16 | 151.72 | -18.17 |
| Operating Profit | 13.5 | 41.03 | -67.1 |
| Net Profit | 9.37 | 26.12 | -64.13 |
| Equity Capital | 12.34 | 14.07 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Hikal | 149.05 | -2.23 | 1837.79 |
| Sequent Scien. | 72.30 | 4.03 | 1762.31 |
| Bliss GVS Pharma | 169.25 | 0.12 | 1744.97 |
| Novartis India | 704.00 | 0.17 | 1738.88 |
| Unichem Labs. | 213.65 | 0.73 | 1504.10 |
| Indoco Remedies | 161.50 | -3.21 | 1488.22 |
| Aarti Drugs | 567.35 | -0.31 | 1337.81 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -6.60% | NA | 0.85% | 0.92% |
| 1 Month | -5.43% | NA | 0.84% | 0.92% |
| 3 Month | -2.98% | NA | -5.86% | -6.17% |
| 6 Month | 12.90% | NA | 0.20% | -0.55% |
| 1 Year | 10.79% | NA | 7.10% | 4.58% |
| 3 Year | -18.33% | NA | 37.64% | 36.84% |
| Today's Low/High | 690.60 |
|
715.00 |
| Week Low/High | 688.00 |
|
772.00 |
| Month Low/High | 675.00 |
|
790.00 |
| YEAR Low/High | 590.00 |
|
980.00 |
| All TIME Low/High | 22.17 |
|
1436.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
